Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-22-114024
Filing Date
2022-11-02
Accepted
2022-11-02 17:01:07
Documents
1
Period of Report
2022-11-02

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2229398d2_6k.htm 6-K 10579
  Complete submission text file 0001104659-22-114024.txt   11605
Mailing Address 77 KING STREET WEST, SUITE 400 C/O DENTONS CANADA LLP TORONTO A6 M5K 0A1
Business Address 1A, 1B LEAROYD ROAD NEW ROMNEY X0 TN28 8XU 442034889514
AKANDA CORP. (Filer) CIK: 0001888014 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41324 | Film No.: 221355047
SIC: 2833 Medicinal Chemicals & Botanical Products